AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Jonathan Corren
Public Documents
2
December 20, 2022
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardl...
Ian Pavord, Arnaud Bourdin, Alberto Papi, et al.
June 24, 2021
COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics...
Marek Jutel, María José Torres, Oscar Palomares, et al.